Skip to main content
Erschienen in: Rheumatology International 7/2017

25.02.2017 | Cases with a Message

Atorvastatin-induced dermatomyositis

verfasst von: Mert Oztas, Serdal Ugurlu, Ovgu Aydin

Erschienen in: Rheumatology International | Ausgabe 7/2017

Einloggen, um Zugang zu erhalten

Abstract

A 49-year-old man with no previous history of musculoskeletal or cutaneous problems who had a myocardial infarction (MI) was treated with atorvastatin, prasugrel, enoxaparine, and diltiazem following percutaneous coronary intervention. He was referred to our rheumatology outpatient clinic for rash and papules on the knuckles, face, and neck, as well as proximal muscle weakness. In the physical examination, a reddish rash on the face and Gottron’s papules on the knuckles were detected. The skin biopsy performed indicated interface dermatitis with hydropic degeneration of basal keratinocytes, supporting the clinical impression of dermatomyositis. He was started on prednisolone 1 mg/kg/day. After 30 days of prednisolone therapy, all symptoms disappeared.
Literatur
1.
Zurück zum Zitat Scandinavian Simvastatin Survival Group (1994) Randomised trial cholesterol lowering in 4444 patients with coronary heart disease: the Scandinavian Simvastatin Survival Study (4S). The Lancet 344(8934):1383–1389 Scandinavian Simvastatin Survival Group (1994) Randomised trial cholesterol lowering in 4444 patients with coronary heart disease: the Scandinavian Simvastatin Survival Study (4S). The Lancet 344(8934):1383–1389
2.
Zurück zum Zitat Downs JR, Clearfield M, Weis S et al (1998) Primary prevention of acute coronary events with lovastatin in men and women with average cholesterol levels: results of AFCAPS/TexCAPS. Air Force/Texas Coronary Atherosclerosis Prevention Study. JAMA 279:1615–1622CrossRefPubMed Downs JR, Clearfield M, Weis S et al (1998) Primary prevention of acute coronary events with lovastatin in men and women with average cholesterol levels: results of AFCAPS/TexCAPS. Air Force/Texas Coronary Atherosclerosis Prevention Study. JAMA 279:1615–1622CrossRefPubMed
3.
Zurück zum Zitat Sacks FM (2004) Do statins play a role in the early management of the acute coronary syndrome? Eur Heart J Suppl 6(Supplement A):A32–A36CrossRef Sacks FM (2004) Do statins play a role in the early management of the acute coronary syndrome? Eur Heart J Suppl 6(Supplement A):A32–A36CrossRef
4.
5.
Zurück zum Zitat Grable-Esposito P, Katzberg HD, Greenberg SA, Srinivasan J, Katz J, Amato AA (2010) Immune-mediated necroziting myopathy associated with statins. Muscle Nerve 41(2):185–190PubMed Grable-Esposito P, Katzberg HD, Greenberg SA, Srinivasan J, Katz J, Amato AA (2010) Immune-mediated necroziting myopathy associated with statins. Muscle Nerve 41(2):185–190PubMed
6.
Zurück zum Zitat Komai E, Takemoto M, Yokote K (2015) Atorvastatin-induced dermatomyositis in a 47-year-old woman with Sjögren’s syndrome. Acta Cardiol 70(3):373CrossRefPubMed Komai E, Takemoto M, Yokote K (2015) Atorvastatin-induced dermatomyositis in a 47-year-old woman with Sjögren’s syndrome. Acta Cardiol 70(3):373CrossRefPubMed
7.
Zurück zum Zitat Noël B, Cerottini JP, Panizzon RG (2001) Atorvastatin-induced Dermatomyositis. Am J Med 110(8):670–671CrossRefPubMed Noël B, Cerottini JP, Panizzon RG (2001) Atorvastatin-induced Dermatomyositis. Am J Med 110(8):670–671CrossRefPubMed
8.
Zurück zum Zitat Cannon CS (2012) Statin-induced rhabdomyolysis and dermatomyositis: A rare combination. JAAPA 25(8):32–33 Cannon CS (2012) Statin-induced rhabdomyolysis and dermatomyositis: A rare combination. JAAPA 25(8):32–33
9.
Zurück zum Zitat Noël B (2004) Statins and lupus erythematosus Rheumotology(Oxford) 43(3):pp 397–398 Noël B (2004) Statins and lupus erythematosus Rheumotology(Oxford) 43(3):pp 397–398
10.
Zurück zum Zitat Taylor BA, Thompson PD (2015) Muscle-related side-effects of statins: from mechanisms to evidence-based solutions. Curr Opin Lipidol 26(3):221–227CrossRefPubMed Taylor BA, Thompson PD (2015) Muscle-related side-effects of statins: from mechanisms to evidence-based solutions. Curr Opin Lipidol 26(3):221–227CrossRefPubMed
11.
Metadaten
Titel
Atorvastatin-induced dermatomyositis
verfasst von
Mert Oztas
Serdal Ugurlu
Ovgu Aydin
Publikationsdatum
25.02.2017
Verlag
Springer Berlin Heidelberg
Erschienen in
Rheumatology International / Ausgabe 7/2017
Print ISSN: 0172-8172
Elektronische ISSN: 1437-160X
DOI
https://doi.org/10.1007/s00296-017-3658-9

Weitere Artikel der Ausgabe 7/2017

Rheumatology International 7/2017 Zur Ausgabe

Leitlinien kompakt für die Innere Medizin

Mit medbee Pocketcards sicher entscheiden.

Seit 2022 gehört die medbee GmbH zum Springer Medizin Verlag

Update Innere Medizin

Bestellen Sie unseren Fach-Newsletter und bleiben Sie gut informiert.